Cargando…
Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas
Introduction Adrenal incidentalomas (AI) are adrenal masses that are discovered during radiological examinations conducted for other reasons. In this study, we focused on the pathological and radiological properties of nonfunctional AI(NFAI) and the association with malignancy risk in our clinical s...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001135/ https://www.ncbi.nlm.nih.gov/pubmed/32051792 http://dx.doi.org/10.7759/cureus.6574 |
_version_ | 1783494177876606976 |
---|---|
author | Vural, Veli Kılınç, Eyyüp M Sarıdemir, Demet Gök, İsmail B Hüseynov, Amil Akbarov, Alim Yaprak, Muhittin |
author_facet | Vural, Veli Kılınç, Eyyüp M Sarıdemir, Demet Gök, İsmail B Hüseynov, Amil Akbarov, Alim Yaprak, Muhittin |
author_sort | Vural, Veli |
collection | PubMed |
description | Introduction Adrenal incidentalomas (AI) are adrenal masses that are discovered during radiological examinations conducted for other reasons. In this study, we focused on the pathological and radiological properties of nonfunctional AI(NFAI) and the association with malignancy risk in our clinical series. Methods A total of 186 patients underwent adrenalectomy between 2010 and 2017; of these, 76 (40.8%) patients with non-functional AI were included in the current study. The radiological and pathologic characteristics of these AIs were retrospectively analyzed to determine the malignancy rate. Results There were 22 (28.9%) male and 54 (71.1%) female patients with nonfunctional AI included in this study. The median age was 55 (range: 24-85) years. Of the patients included, 37 (48.6%) had AI on the left and 39 (51.3%) had AI on the right adrenal gland. Sixty-one (80.2%) cases were treated laparoscopically, four (5.3%) required conversion to open surgery due to intraoperative difficulties such as bleeding and adhesions, and 11 (14.4%) were managed with open adrenalectomy. The rate of malignancy in the tumors with diameters of <4 cm, 4-6 cm, and >6 cm was found to be 0%, 2.9%, and 13.6%, respectively. Conclusions Determining the ideal cutoff value for surgical indication in an NFAI is challenging. Besides the malignancy risk, the rate of silent pheochromacytomas must be taken into account in the surgical decision. |
format | Online Article Text |
id | pubmed-7001135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-70011352020-02-12 Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas Vural, Veli Kılınç, Eyyüp M Sarıdemir, Demet Gök, İsmail B Hüseynov, Amil Akbarov, Alim Yaprak, Muhittin Cureus Endocrinology/Diabetes/Metabolism Introduction Adrenal incidentalomas (AI) are adrenal masses that are discovered during radiological examinations conducted for other reasons. In this study, we focused on the pathological and radiological properties of nonfunctional AI(NFAI) and the association with malignancy risk in our clinical series. Methods A total of 186 patients underwent adrenalectomy between 2010 and 2017; of these, 76 (40.8%) patients with non-functional AI were included in the current study. The radiological and pathologic characteristics of these AIs were retrospectively analyzed to determine the malignancy rate. Results There were 22 (28.9%) male and 54 (71.1%) female patients with nonfunctional AI included in this study. The median age was 55 (range: 24-85) years. Of the patients included, 37 (48.6%) had AI on the left and 39 (51.3%) had AI on the right adrenal gland. Sixty-one (80.2%) cases were treated laparoscopically, four (5.3%) required conversion to open surgery due to intraoperative difficulties such as bleeding and adhesions, and 11 (14.4%) were managed with open adrenalectomy. The rate of malignancy in the tumors with diameters of <4 cm, 4-6 cm, and >6 cm was found to be 0%, 2.9%, and 13.6%, respectively. Conclusions Determining the ideal cutoff value for surgical indication in an NFAI is challenging. Besides the malignancy risk, the rate of silent pheochromacytomas must be taken into account in the surgical decision. Cureus 2020-01-06 /pmc/articles/PMC7001135/ /pubmed/32051792 http://dx.doi.org/10.7759/cureus.6574 Text en Copyright © 2020, Vural et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Vural, Veli Kılınç, Eyyüp M Sarıdemir, Demet Gök, İsmail B Hüseynov, Amil Akbarov, Alim Yaprak, Muhittin Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas |
title | Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas |
title_full | Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas |
title_fullStr | Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas |
title_full_unstemmed | Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas |
title_short | Association between Tumor Size and Malignancy Risk in Hormonally Inactive Adrenal Incidentalomas |
title_sort | association between tumor size and malignancy risk in hormonally inactive adrenal incidentalomas |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001135/ https://www.ncbi.nlm.nih.gov/pubmed/32051792 http://dx.doi.org/10.7759/cureus.6574 |
work_keys_str_mv | AT vuralveli associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas AT kılınceyyupm associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas AT sarıdemirdemet associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas AT gokismailb associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas AT huseynovamil associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas AT akbarovalim associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas AT yaprakmuhittin associationbetweentumorsizeandmalignancyriskinhormonallyinactiveadrenalincidentalomas |